Philadelphia-based software provider eResearch Technology (ERT) was hit two weeks ago by a ransomware attack that has slowed clinical trials.
The exploit started when ERT workers learned that they were locked out of their data, and clients said this forced researchers to move certain clinical trials to pen and paper.
ERT's Drew Bustos on Friday verified that ransomware had hijacked company systems on Sept. 20, when the firm took its systems offline, called in outside cybersecurity experts, and alerted the U.S. Federal Bureau of Investigation.
Affected customers included IQVIA, the contract research organization helping manage AstraZeneca's Covid-19 vaccine trial, and drug maker Bristol Myers Squibb, which is leading a consortium in developing a rapid test for coronavirus.
From The New York Times
View Full Article - May Require Paid Subscription
Abstracts Copyright © 2020 SmithBucklin, Washington, DC, USA
No entries found